- This event has passed.
June 16 @ 10:00 am - 11:00 am UTC-7
One year ago, the Death of George Floyd sparked a worldwide movement for racial equality and justice. There was an outcry of support from corporates and startups alike. There were press releases and social posts advocating for diversity, equity, inclusion—and industry-wide change. This month Let’s Talk About will examine how the life science industry has changed, how companies have approached DEI initiatives, and what start-ups can do to make their work culture inclusive.
Candace Nortey, M.S., Executive Director of Diversity, Equity, and Inclusion, Slone Partners
Candace Nortey is a strategic planner, consultant, innovator, and executive trainer who serves as Slone Partners’ Executive Director of Diversity, Equity, and Inclusion (DEI). In her role, Nortey guides and expands the company’s programming designed to enhance opportunities for minority candidates, and manages Slone Partners’ DEI line of products and services, customized to meet the needs of client partners seeking DEI consult, guidance, and strategic planning. She also provides operational support for the company’s ENVISION mentorship program, connecting students from underrepresented communities with accomplished professions in the life science industry.
Rizwana Seeham, Mgr., Quality Assurance & Co-Chair, ED&I Committee, Blueprint Medicines
As her day job, Rizwana works within the biotechnology quality assurance realm, having served in roles across both biologics and small molecules companies. In 2018, Rizwana joined Blueprint Medicines to support their avapritinib program, serving as the drug product lead when the program graduated to become Blueprint’s first commercial product, both in the US and EU (commercialized as AYVAKIT (US)/AYVAKYT (EU)). Alongside continuing her role within the avapritinib program, Rizwana’s responsibilities have evolved within Blueprint.